Cargando…
Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation
Breast cancer is the primary factor contributing to female mortality worldwide. The incidence has overtaken lung cancer. It is the most difficult illness due to its heterogeneity and is made up of several subtypes, including Luminal A and B, basal-like, Her-2 overexpressed and TNBC. Amongst differen...
Autores principales: | Qayoom, Hina, Alshehri, Bader, Ul Haq, Burhan, Almilaibary, Abdullah, Alkhanani, Mustfa, Ahmad Mir, Manzoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641555/ https://www.ncbi.nlm.nih.gov/pubmed/37964781 http://dx.doi.org/10.1016/j.sjbs.2023.103848 |
Ejemplares similares
-
Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation
por: sofi, Shazia, et al.
Publicado: (2023) -
Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation
por: Qayoom, Hina, et al.
Publicado: (2023) -
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
por: Sofi, Shazia, et al.
Publicado: (2022) -
Immunotherapies against human bacterial and fungal infectious diseases: A review
por: Qadri, Hafsa, et al.
Publicado: (2023) -
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
por: Mehraj, Umar, et al.
Publicado: (2022)